Trump and RFK Jr promoted leucovorin for autism, FDA later limited approval

Trump and RFK Jr touted leucovorin as a treatment for autism. The FDA quietly walked it back

Outpatient prescriptions for the drug increased 71% after the announcement, but the FDA later approved it only for folate deficiency When Donald Trump and Robert F Kennedy Jr stood up at the press conference in September to tout leucovorin, a vitamin B derivative, as a treatment for autism, some neurodevelopmental doctors were shocked – and they braced themselves. There was little evidence to suggest the folinic acid helps with autism, yet there was an immediate flood of parents calling and ...

By Melody Schreiber